Author:
Zhao Chenyang,Wang Fengli,Huang Jihan,Lv Yinghua,Yin Fang,Liu Hongxia,Zheng Qingshan,Li Lujin
Funder
Shanghai S&T Innovation Plan
National Major Science and Technology Projects of China
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference43 articles.
1. Huang J, Ding Z, Luo Q, Xu W (2019) Cancer cell-derived exosomes promote cell proliferation and inhibit cell apoptosis of both normal lung fibroblasts and non-small cell lung cancer cell through delivering alpha-smooth muscle actin. Am J Transl Res 11:1711–1723
2. Lee SH (2019) Chemotherapy for lung cancer in the era of personalized medicine. Tuberc Respir Dis (Seoul) 82:179–189
3. Horita N, Nagashima A, Nakashima K, Shibata Y, Ito K, Goto A, Yamanaka T, Kaneko T (2017) The best platinum regimens for chemo-naive incurable non-small cell lung cancer: network meta-analysis. Sci Rep 7:13185
4. de Castria TB, da Silva EM, Gois AF, Riera R (2013) Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer. Cochrane Database Syst Rev:CD009256
5. Gao G, Chu H, Zhao L, Gui T, Xu Q, Shi J (2012) A meta-analysis of paclitaxel-based chemotherapies administered once every week compared with once every 3 weeks first-line treatment of advanced non-small-cell lung cancer. Lung Cancer 76:380–386
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献